SouthState Corp’s Precision BioSciences DTIL Stock Holding History

SouthState Corp’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$523	Hold	95	–	–	﹤0.01%	1174
2025 Q4	$395	Hold	95	–	–	﹤0.01%	1263
2025 Q3	$524	Hold	95	–	–	﹤0.01%	1231
2025 Q2	$399	Hold	95	–	–	﹤0.01%	1478
2025 Q1	$453	Hold	95	–	–	﹤0.01%	1549
2024 Q4	$362	Hold	95	–	–	﹤0.01%	662
2024 Q3	$851	Hold	95	–	–	﹤0.01%	588
2024 Q2	$924	Buy	+95	New	+$1.12K	﹤0.01%	613
2024 Q1	–	Sell	-95	Closed	-$1.04K	–	691
2023 Q4	$1.04K	Hold	95	–	–	﹤0.01%	562
2023 Q3	$973	Hold	95	–	–	﹤0.01%	596
2023 Q2	$1.5K	Hold	95	–	–	﹤0.01%	558
2023 Q1	$2.15K	Buy	+95	New	+$3.13K	﹤0.01%	596

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SouthState Corp's DTIL Position: Q1 2026 in Review

SouthState Corp held its Precision BioSciences (DTIL) position steady in Q1 2026 at 95 shares worth $523. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

SouthState Corp first reported a position in DTIL in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.15K in Q1 2023. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

SouthState Corp held 95 shares of Precision BioSciences worth $523 as of Q1 2026.
SouthState Corp left its Precision BioSciences share count unchanged in Q1 2026.
Precision BioSciences made up ﹤0.01% of SouthState Corp's portfolio in Q1 2026, its #1174 holding.
SouthState Corp first reported a position in Precision BioSciences in Q1 2023 and has held it in 12 quarters since.
SouthState Corp's Precision BioSciences position peaked at $2.15K in Q1 2023.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.